{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:59:28Z","timestamp":1769857168733,"version":"3.49.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["JP20he082206"],"award-info":[{"award-number":["JP20he082206"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Kakenhi","doi-asserted-by":"crossref","award":["20K20200"],"award-info":[{"award-number":["20K20200"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hyogo prefecture"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global threat. To forestall the pandemic, developing safe and effective vaccines is necessary. Because of the rapid production and little effect on the host genome, mRNA vaccines are attractive, but they have a relatively low immune response after a single dose. Replicon RNA (repRNA) is a promising vaccine platform for safety and efficacy. RepRNA vaccine encodes not only antigen genes but also the genes necessary for RNA replication. Thus, repRNA is self-replicative and can play the role of an adjuvant by itself, which elicits robust immunity. This study constructed and evaluated a repRNA vaccine in which the gene encoding the spike (S) protein of SARS-CoV-2 was inserted into a replicon of yellow fever virus 17D strain. Upon electroporation of this repRNA into baby hamster kidney cells, the S protein and yellow fever virus protein were co-expressed. Additionally, the self-replication ability of repRNA vaccine was confirmed using qRT-PCR, demonstrating its potency as a vaccine. Immunization of C57BL\/6 mice with 1 \u03bcg of the repRNA vaccine induced specific T-cell responses but not antibody responses. Notably, the T-cell response induced by the repRNA vaccine was significantly higher than that induced by the nonreplicative RNA vaccine in our experimental model. In the future, it is of the essence to optimize vaccine administration methods and improve S protein expression, like protection of repRNA by nanoparticles and evasion of innate immunity of the host to enhance the immune-inducing ability of the repRNA vaccine.<\/jats:p>","DOI":"10.1371\/journal.pone.0274829","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:24:22Z","timestamp":1666290262000},"page":"e0274829","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Construction and evaluation of a self-replicative RNA vaccine against SARS-CoV-2 using yellow fever virus replicon"],"prefix":"10.1371","volume":"17","author":[{"given":"Akina","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-8278","authenticated-orcid":true,"given":"Tomohiro","family":"Kotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurie","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Takazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5525-9915","authenticated-orcid":true,"given":"Masanori","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"pone.0274829.ref001","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","volume":"12","author":"JH Erasmus","year":"2020","journal-title":"Sci Transl Med"},{"key":"pone.0274829.ref002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajem.2022.01.028","article-title":"Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation","volume":"54","author":"B Long","year":"2022","journal-title":"Am J Emerg Med"},{"key":"pone.0274829.ref003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40001-021-00513-x","article-title":"Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study","volume":"26","author":"S SeyedAlinaghi","year":"2021","journal-title":"Eur J Med Res"},{"key":"pone.0274829.ref004","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1002\/iid3.670","article-title":"Immunologic features of asymptomatic postvaccination infections with the Delta variant of SARS-CoV-2 in adults","volume":"10","author":"R Duan","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"pone.0274829.ref005","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.mayocp.2020.07.021","article-title":"SARS-CoV-2 vaccine development: current status","volume":"95","author":"GA Poland","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"pone.0274829.ref006","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/jmv.27697","article-title":"Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: A systematic review","volume":"94","author":"S Chenchula","year":"2022","journal-title":"J Med Virol"},{"key":"pone.0274829.ref007","first-page":"iqab010","article-title":"Overview of approved and upcoming vaccines for SARS-CoV-2: a living review","volume":"5","author":"Oxford-Cardiff COVID-19 Literature Consortium","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"pone.0274829.ref008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1473-3099(21)00674-5","article-title":"Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study","volume":"3","author":"D Desai","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"pone.0274829.ref009","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: what, why and how","volume":"17","author":"JW Park","year":"2021","journal-title":"Int J Biol Sci"},{"key":"pone.0274829.ref010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/vaccines9111211","article-title":"RNA vaccines against infectious diseases: vital progress with room for improvement","volume":"9","author":"HM Abdelzaher","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"pone.0274829.ref011","doi-asserted-by":"crossref","first-page":"e2111075118","DOI":"10.1073\/pnas.2111075118","article-title":"Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice","volume":"118","author":"J Guti\u00e9rrez-\u00c1lvarez","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0274829.ref012","doi-asserted-by":"crossref","first-page":"e29732","DOI":"10.1371\/journal.pone.0029732","article-title":"Intradermal electroporation of naked replicon RNA elicits strong immune responses","volume":"7","author":"DX Johansson","year":"2012","journal-title":"PLoS One"},{"key":"pone.0274829.ref013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2010.11.024","article-title":"Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone\u00ae in rhesus macaques","volume":"29","author":"TD Carroll","year":"2011","journal-title":"Vaccine"},{"key":"pone.0274829.ref014","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"DI Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"pone.0274829.ref015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"AB Vogel","year":"2018","journal-title":"Mol Ther"},{"key":"pone.0274829.ref016","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine\u2014how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"AD Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"pone.0274829.ref017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","article-title":"Viruses as vaccine vectors for infectious diseases and cancer","volume":"8","author":"SJ Draper","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"pone.0274829.ref018","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"S Matsuyama","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0274829.ref019","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1099\/vir.0.019851-0","article-title":"Replication of not-known-vector flaviviruses in mosquito cells is restricted by intracellular host factors rather than by the viral envelope proteins","volume":"91","author":"N Charlier","year":"2010","journal-title":"J Gen Virol"},{"key":"pone.0274829.ref020","doi-asserted-by":"crossref","first-page":"12987","DOI":"10.1038\/s41598-021-92403-9","article-title":"An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency","volume":"11","author":"T Kotaki","year":"2021","journal-title":"Sci Rep"},{"key":"pone.0274829.ref021","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00705-012-1240-z","article-title":"Construction of an infectious cDNA clone of Culex flavivirus, an insect-specific flavivirus from Culex mosquitoes","volume":"157","author":"H Isawa","year":"2012","journal-title":"Arch Virol"},{"key":"pone.0274829.ref022","doi-asserted-by":"crossref","first-page":"16160","DOI":"10.1038\/s41598-017-16475-2","article-title":"Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV\/Hu\/S36\/Chiba\/2016","volume":"7","author":"F Kato","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0274829.ref023","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An Mrna vaccine against SARS-Cov-2\u2014preliminary report","volume":"383","author":"LA Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0274829.ref024","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-Cov-2 is essential for infection of human lung cells","volume":"78","author":"M Hoffmann","year":"2020","journal-title":"Mol Cell"},{"key":"pone.0274829.ref025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An infectious cDNA clone of SARS-CoV-2","volume":"27","author":"X Xie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"pone.0274829.ref026","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"J Schindelin","year":"2012","journal-title":"Nature methods"},{"key":"pone.0274829.ref027","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41467-021-21118-2","article-title":"SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity","volume":"12","author":"S Ozono","year":"2021","journal-title":"Nat Commun"},{"key":"pone.0274829.ref028","doi-asserted-by":"crossref","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","article-title":"Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7","volume":"35","author":"B Meng","year":"2021","journal-title":"Cell Rep"},{"key":"pone.0274829.ref029","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.3390\/molecules23123310","article-title":"Self-replicating RNA viruses for RNA therapeutics","volume":"23","author":"K. Lundstrom","year":"2018","journal-title":"Molecules"},{"key":"pone.0274829.ref030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00239-021-10008-2","article-title":"The evolution of severe acute respiratory syndrome coronavirus-2 during pandemic and adaptation to the host","volume":"89","author":"S Hussain","year":"2021","journal-title":"J Mol Evol"},{"key":"pone.0274829.ref031","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41422-020-00392-7","article-title":"A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice","volume":"30","author":"J Lu","year":"2020","journal-title":"Cell Res"},{"key":"pone.0274829.ref032","doi-asserted-by":"crossref","first-page":"622385","DOI":"10.3389\/fimmu.2020.622385","article-title":"Self-amplifying pestivirus replicon RNA encoding influenza virus nucleoprotein and hemagglutinin promote humoral and cellular immune responses in pigs","volume":"11","author":"T D\u00e9moulins","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0274829.ref033","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design","volume":"198","author":"T Pepini","year":"2017","journal-title":"J Immunol"},{"key":"pone.0274829.ref034","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/vaccines7030096","article-title":"Immunogenicity and protection efficacy of a naked self-replicating mRNA-based zika virus vaccine","volume":"7","author":"Z Zhong","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"pone.0274829.ref035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/vaccines9010061","article-title":"Immune responses induced by mRNA vaccination in mice, monkeys and humans","volume":"9","author":"A Cagigi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"pone.0274829.ref036","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.02032-06","article-title":"Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation","volume":"81","author":"O Bauhofer","year":"2007","journal-title":"J Virol"},{"key":"pone.0274829.ref037","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"K Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"pone.0274829.ref038","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13059-021-02557-y","article-title":"Interferon inducible pseudouridine modification in human mRNA by quantitative nanopore profiling","volume":"22","author":"S Huang","year":"2021","journal-title":"Genome Biol"},{"key":"pone.0274829.ref039","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"F Tang","year":"2011","journal-title":"J Immunol"},{"key":"pone.0274829.ref040","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T-cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"A Grifoni","year":"2020","journal-title":"Cell"},{"key":"pone.0274829.ref041","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2013.03.025","article-title":"Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses","volume":"168","author":"P Li","year":"2013","journal-title":"J Control Release"},{"key":"pone.0274829.ref042","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4049\/immunohorizons.1800078","article-title":"Signaling cross-talk between MHC Class II molecular conformers in resting murine B cells","volume":"3","author":"JR Drake","year":"2019","journal-title":"Immunohorizons"},{"key":"pone.0274829.ref043","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/s41422-020-00405-5","article-title":"A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles","volume":"30","author":"YN Zhang","year":"2020","journal-title":"Cell Res"},{"key":"pone.0274829.ref044","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1126\/science.abj8430","article-title":"Replication and single-cycle delivery of SARS-CoV-2 replicons","volume":"374","author":"I Ricardo-Lax","year":"2021","journal-title":"Science"},{"key":"pone.0274829.ref045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01317496","article-title":"Studies on avian infectious bronchitis virus (IBV). III. Interferon induction by and sensitivity to interferon of IBV","volume":"60","author":"K Otsuki","year":"1979","journal-title":"Arch Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:25:03Z","timestamp":1666290303000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0274829"}},"subtitle":[],"editor":[{"given":"Victor C","family":"Huber","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0274829","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}